发明授权
US5498625A Substantially pure enantieners of 2-azabicyclo(2.2.1)hept-5-en-3-one
失效
基本纯的2-氮杂双环(2.2.1)庚-5-烯-3-酮的对映体
- 专利标题: Substantially pure enantieners of 2-azabicyclo(2.2.1)hept-5-en-3-one
- 专利标题(中): 基本纯的2-氮杂双环(2.2.1)庚-5-烯-3-酮的对映体
-
申请号: US336754申请日: 1994-11-08
-
公开(公告)号: US5498625A公开(公告)日: 1996-03-12
- 发明人: Christopher T. Evans , Stanley M. Roberts
- 申请人: Christopher T. Evans , Stanley M. Roberts
- 申请人地址: GB2 Cambridge
- 专利权人: Chiroscience Limited
- 当前专利权人: Chiroscience Limited
- 当前专利权人地址: GB2 Cambridge
- 优先权: GBX8923278 19891016; GBX8924209 19891027; GBX9000995 19900117
- 主分类号: C12N9/86
- IPC分类号: C12N9/86 ; C07D209/52 ; C07D491/08 ; C07D498/04 ; C07D498/08 ; C12N1/20 ; C12P13/00 ; C12P17/10 ; C12P41/00 ; C12R1/01 ; A01N43/38 ; C07C7/00 ; C07D207/12 ; C12N9/78
摘要:
Lactams of 1-amino-3-carboxylic acid cyclic compounds are produced in enantiomeric form, together with an enantiomer of the corresponding ring-opened amino-acid or ester, by reaction of the racemic lactam with a novel lactamase. The products are useful in the synthesis of chiral carbocyclic nucleotides. The enantiomer is preferrably 2-azabicyclo(2.2.1)hept-5-en-3-one. It is desirable to isolate the enantiomer comprising predominantly the (+) enantiomer and a residual amount of the (-) enantiomer, wherein the (+) enantiomer is present in an enantiomeric excess of at least about 88% over the (-) enantiomer or the enantiomer comprising predominantly the (-) enantiomer and a residual amount of the (+) enantiomer, wherein the (-) enantiomer is present in an enantiomeric excess of at least about 98% over the (+) enantiomer.
公开/授权文献
信息查询
IPC分类: